Back

Results - Announcements

Sales rise 27.48% to Rs 76.27 crore

Balaxi Pharmaceuticals consolidated net profit declines 20.95% in the March 2025 quarter

31-May-2025, 07:50
Net profit of Balaxi Pharmaceuticals declined 20.95% to Rs 8.64 crore in the quarter ended March 2025 as against Rs 10.93 crore during the previous quarter ended March 2024. Sales rose 27.48% to Rs 76.27 crore in the quarter ended March 2025 as against Rs 59.83 crore during the previous quarter ended March 2024.

For the full year,net profit declined 30.19% to Rs 25.07 crore in the year ended March 2025 as against Rs 35.91 crore during the previous year ended March 2024. Sales rose 21.25% to Rs 292.56 crore in the year ended March 2025 as against Rs 241.29 crore during the previous year ended March 2024.

Particulars	Quarter Ended			Year Ended
	Mar. 2025	Mar. 2024	% Var.	Mar. 2025	Mar. 2024	% Var.
Sales	76.27	59.83	27	292.56	241.29	21
OPM %	16.45	22.51	-	12.72	19.37	-
PBDT	10.12	11.07	-9	30.56	42.41	-28
PBT	9.66	10.40	-7	28.67	40.31	-29
NP	8.64	10.93	-21	25.07	35.91	-30